People: Pacira Pharmaceuticals Inc (PCRX.O)

PCRX.O on Nasdaq

95.93USD
1 Aug 2014
Price Change (% chg)

$3.93 (+4.27%)
Prev Close
$92.00
Open
$91.92
Day's High
$96.95
Day's Low
$91.08
Volume
757,484
Avg. Vol
475,207
52-wk High
$96.95
52-wk Low
$30.75

Search Stocks

Scibetta, James 

Brief Biography

Mr. James S. Scibetta is Chief Financial Officer, Senior Vice President of Pacira Pharmaceuticals Inc. Prior to that, Mr. Scibetta was chief financial officer of Bioenvision, Inc. (NASDAQ: BIVN) from 2006 until its acquisition by Genzyme, Inc. in 2007. From 2001 to 2006, Mr. Scibetta was executive vice president and chief financial officer of Merrimack Pharmaceuticals, Inc., and he was a member of the board of directors of Merrimack from 1998 to 2004. Mr. Scibetta formerly served as a senior investment banker at Shattuck Hammond Partners, LLC and PaineWebber Inc., providing capital acquisition, merger and acquisition, and strategic advisory services to healthcare companies. He currently serves as chairman of the board and audit committee of Nephros, Inc. (NASDAQ: NEPH). Mr. Scibetta holds a B.S. in physics from Wake Forest University, and an M.B.A. in finance from the University of Michigan. He completed executive education studies in the Harvard Business School Leadership & Strategy in Pharmaceuticals and Biotechnology program.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
468,400 -- 630 469,030

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 40,000 1,523,830.00
Name Fiscal Year Total

David Stack

918,972

James Scibetta

469,030

Taunia Markvicka

459,530

Gary Patou

367,600

Laura Brege

--

Yvonne Greenstreet

--
As Of 30 Dec 2013
Search Stocks